Centene Swings to $2.19 EPS in Q2, Raises Cash Flow, and Plans Major Workforce Cuts
CNC has more than doubled off its 52-week low of $25.075.
Summary
Centene reported Q2 2026 GAAP EPS of $2.19, a dramatic swing from a loss of $0.51 a year ago, fueled by a much lower medical cost ratio and strong cash flow. The company also announced a large voluntary separation program that will cost $315–$365 million in severance.
Key Events · Earnings and Guidance · CNC
-
Earnings Swing to Profit
Q2 2026 GAAP diluted EPS of $2.19 vs. a loss of $0.51 in Q2 2025. Adjusted diluted EPS was $2.51 vs. a loss of $0.16.
-
Health Benefits Ratio Improves Sharply
HBR fell to 89.6% from 93.0% a year ago, driven by Marketplace pricing actions, favorable risk adjustment, and no Medicare Advantage premium deficiency reserve in 2026.
-
Massive Workforce Reduction Planned
A voluntary separation program will incur $315M–$365M in severance costs in H2 2026, part of enterprise optimization efforts.
-
Operating Cash Flow Surges
Operating activities provided $3.6B in Q2 2026, up from $3.3B in the first half of 2025, aided by timing of pass-through payments.
Analysis · CNC · Finance
A sharp earnings turnaround defined Centene's Q2 2026, with GAAP diluted EPS reaching $2.19 compared to a loss of $0.51 a year ago. The dramatic improvement stemmed from a much lower health benefits ratio—89.6% versus 93.0%—reflecting better pricing and risk adjustment in the Marketplace business, along with the absence of a Medicare Advantage premium deficiency reserve that had burdened 2025 results. Operating cash flow surged to $3.6 billion, and the company aggressively reduced debt by $1.3 billion. However, a voluntary separation program was also announced, which will trigger $315–$365 million in severance costs in the second half of 2026, signaling a major cost-cutting push amid ongoing membership declines and regulatory headwinds. While the results handily beat the prior-year period and suggest pricing actions are taking hold, the workforce reduction and membership losses keep the outlook mixed.
At the time of this filing, CNC was trading at $67.38 on NYSE in the Finance sector, with a market capitalization of approximately $31.6B. The 52-week trading range was $25.08 to $69.36. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.